Home  |   Archive  |   Online Submission  |   News & Events  |   Subscribe  |   APFA  |   Society  |   Contact Us  |   中文版
Search   
 
Journal

Ahead of print
Authors' Accepted
    Manuscripts
new!
Current Issue
Archive
Acknowledgments
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us
News

Resources & Services

Advertisement
Subscription
Email alert
Proceedings
Reprints

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the
    authors

AJA Club (in English)
AJA Club (in Chinese)

 
中文摘要

《亚洲男性学杂志》 2013; 15 (1): 143-148

淫羊藿次苷Ⅱ对DM性ED大鼠阴茎勃起功能、AGEs、自噬、mTOR 和 NO-cGMP影响及其机制的研究

Jian Zhang, Ai-Min Li, Bao-Xing Liu, Fei Han, Feng Liu, Shao-Peng Sun, Xin Li, Shu-Jin Cui, Shao-Zhong Xian, Guang-Qi Kong, Zhong-Cheng Xin and Zhi-Li Ji (中国)

勃起功能障碍(ED)是糖尿病的主要并发症,并且已经被证实淫羊藿苷是通过其生物活性形式淫羊藿次苷Ⅱ发挥作用而增强勃起功能。本实验研究淫羊藿次苷Ⅱ对DM性ED大鼠阴茎勃起功能、阴茎海绵体组织中晚期糖基化终产物(AGEs)、自噬、mTOR和NO-cGMP信号通路影响及其机制。通过酶化学法从淫羊藿苷分离提纯出淫羊藿次苷Ⅱ。淫羊藿次苷Ⅱ作用糖尿病ED组大鼠灌胃淫羊藿次苷Ⅱ,而正常对照组和糖尿病ED组大鼠分别灌胃相应量的生理盐水。阴茎海绵体压力和平均动脉压比值(ICP/MAP)测定同组别大鼠阴茎勃起功能,酶联免疫法测定不同组别大鼠海绵体组织中AGEs、NOS活性和cGMP含量,四甲基偶氮唑盐微量酶反应比色方法(MTT法)和流式细胞仪法分析细胞增殖状况。透射电子显微镜法、单丹磺酰尸胺(MDC)染色法和GFP-LC3荧光自噬共定位法观察测定自噬状况,蛋白质免疫印迹法测定NOS异构体和自噬的关键蛋白的表达;并比较三组间上述指标的差异程度。在淫羊藿次苷Ⅱ作用糖尿病ED组大鼠中,淫羊藿次苷Ⅱ增加了ICP/MAP、平滑肌细胞生长曲线、S期和平滑肌细胞含量,而降低了Beclin1(P<0.05);淫羊藿次苷Ⅱ显著增加了平滑肌细胞增殖指数和p-p70S6K (Thr389)表达,显著减弱了平滑肌细胞中的自噬和LC3-II表达(P<0.01);淫羊藿次苷Ⅱ减弱了AGEs,增加cGMP含量和NOS活性(P<0.05),并且显著增加了cNOS(P<0.01)。淫羊藿次苷Ⅱ明显改善DM性ED大鼠阴茎勃起功能,这可能与淫羊藿次苷Ⅱ上调阴茎海绵体平滑肌细胞增殖和NO-cGMP信号通路及下调AGEs、自噬和mTOR信号通路有关。

关键词:晚期糖基化终产物(AGEs),自噬,细胞增殖,糖尿病,勃起功能障碍,淫羊藿,淫羊藿次苷Ⅱ,mTOR,NO-cGMP,NOS活性

此摘要文献来源:
Jian Zhang, Ai-Min Li, Bao-Xing Liu, Fei Han, Feng Liu, et al. Effect of icarisid II on diabetic rats with erectile dysfunction and its potential mechanism via assessment of AGEs, autophagy, mTOR and the NO–cGMP pathway. Asian J Androl 2013;15: 143-148.

 
Asian Journal of Andrology CN 31-1795/R ISSN 1008-682X  Copyright © 2023  Shanghai Materia Medica, Chinese Academy of Sciences.  All rights reserved.